Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDA2: Insulin degludec + insulin aspart vs sliding scale insulin in hospitalized type 2 diabetes
2016-002910-38Phase 4Terminated
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Aug 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin degludec and insulin aspart in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Copenhagen University Hospital - Hvidovre. Primary endpoint: Mean daily plasma glucose. Started Aug 2016; status: terminated.
02
Drugs
insulin degludecinsulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-002910-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002910-38.